Market Research

The liquid handling system market will reach a value of USD 6,521 million by 2030, powering at a compound annual growth rate of 4.20% by the end of this decade. The growth of the industry has a lot to do with the booming life sciences sector, growing incidence of chronic ailments, and increasing investment by corporations for emerging advanced and efficient therapeutic agents.

In the recent past, pipettes held the largest share, of more than 21%, in the liquid handling system market, and this tre

The ligase enzyme is responsible for forming fresh covalent connections between two molecules. Ligases, like other enzymes, have proteins with a target molecule recognition area integrated inside them. This gives the enzymatic process an active location to occur. 

Different ligases are used to catalyze different kinds of covalent bonds, such as the carbon-nitrogen, carbon-carbon, and carbon-sulfur bonds. The process is catalyzed by a guanosine-5'-triphosphate or adenosine triphosphate molecule,

The cardiac biomarkers market will generate a value of USD 20,718.8 million by 2030, powering at a compound annual growth rate of 10.5% by the end of this decade. This is because of the growing incidence of ACS, tech progressions in cardiac biomarkers, increasing demand for point-of-care testing kits, and requirement for high specificity in the recognition of cardiac disorders, chiefly myocardial infarction. 

Troponin had the major revenue share of, more than 35%, in the recent past, and this wil

The laboratory informatics market had the revenue of USD 4,376.2 million in 2023, which will power at a rate of 11.4% by the end of this decade, reaching USD 9,176.6 million by 2030.

The development of this industry is mostly powered by the increase in the requirement for laboratory automation, along with for biobanks/biorepositories and an increase in R&D expenditure in the biotech and pharma sectors.

On the basis of product, LIMS had the largest share, of 30%, in 2023, and it will continue to

The recombinant proteins market is witnessing growth and is projected to reach USD 3,203.7 million by 2030. The increasing occurrence of numerous rare illnesses, like neutropenia, multiple sclerosis, anemia, cerebral apoplexy, and dwarfism, is driving the need for medications on the basis of recombinant proteins.

Furthermore, such agents are utilized in the advancements of novel treatments for severe chronic illnesses, such as cardiovascular diseases, cancer, viral diseases, and endocrine diseas